Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 4
1969 2
1970 3
1973 1
1974 1
1984 1
1989 1
1990 5
1995 2
1996 1
1999 1
2001 3
2002 2
2003 3
2005 3
2006 7
2007 13
2008 11
2009 12
2010 8
2011 14
2012 14
2013 13
2014 7
2015 18
2016 14
2017 20
2018 28
2019 25
2020 28
2021 25
2022 33
2023 29
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Results by year

Filters applied: . Clear all
Page 1
Thyroid cancer.
Cabanillas ME, McFadden DG, Durante C. Cabanillas ME, et al. Among authors: durante c. Lancet. 2016 Dec 3;388(10061):2783-2795. doi: 10.1016/S0140-6736(16)30172-6. Epub 2016 May 27. Lancet. 2016. PMID: 27240885 Review.
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Filetti S, et al. Among authors: durante c. Ann Oncol. 2019 Dec 1;30(12):1856-1883. doi: 10.1093/annonc/mdz400. Ann Oncol. 2019. PMID: 31549998 Free article. No abstract available.
Contemporary Thyroid Nodule Evaluation and Management.
Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Grani G, et al. Among authors: durante c. J Clin Endocrinol Metab. 2020 Sep 1;105(9):2869-83. doi: 10.1210/clinem/dgaa322. J Clin Endocrinol Metab. 2020. PMID: 32491169 Free PMC article. Review.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.
Filetti S, Durante C, Hartl DM, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Filetti S, et al. Among authors: durante c. Ann Oncol. 2022 Jul;33(7):674-684. doi: 10.1016/j.annonc.2022.04.009. Epub 2022 Apr 28. Ann Oncol. 2022. PMID: 35491008 Free article. No abstract available.
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2).
Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Massa M, Bellantone R, Pontecorvi A, Montesano T, Pagano L, Daniele L, Fugazzola L, Ceresini G, Bruno R, Rossetto R, Tumino S, Centanni M, Meringolo D, Castagna MG, Salvatore D, Nicolucci A, Lucisano G, Filetti S, Durante C. Lamartina L, et al. Among authors: durante c. Endocr Relat Cancer. 2018 Mar;25(3):L7-L11. doi: 10.1530/ERC-17-0453. Epub 2017 Nov 30. Endocr Relat Cancer. 2018. PMID: 29192093 Free article. No abstract available.
International Expert Consensus on US Lexicon for Thyroid Nodules.
Durante C, Hegedüs L, Na DG, Papini E, Sipos JA, Baek JH, Frasoldati A, Grani G, Grant E, Horvath E, Hoang JK, Mandel SJ, Middleton WD, Ngu R, Orloff LA, Shin JH, Trimboli P, Yoon JH, Tessler FN. Durante C, et al. Radiology. 2023 Oct;309(1):e231481. doi: 10.1148/radiol.231481. Radiology. 2023. PMID: 37906014 Review.
306 results